Neoplasms, Connective and Soft Tissue  >>  docetaxel  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
docetaxel / Generic mfg.
NCT00142571: Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Completed
3
120
US
Gemcitabine, Docetaxel
Memorial Sloan Kettering Cancer Center, Connective Tissue Oncology Society, M.D. Anderson Cancer Center, Massachusetts General Hospital, Mayo Clinic, University of Michigan Rogel Cancer Center
Sarcoma, Soft Tissue
 
09/07

Download Options